Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Aralez Pharmaceuticals Inc. (ARLZ)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsMar-31-18Dec-31-17Sep-30-17Jun-30-17Mar-31-17Dec-31-16Sep-30-16Jun-30-16
   10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q
Total revenues   [+]118.1105.997.987.272.254.340.232.4
            Revenue growth  63.6%95.2%143.4%169.0%188.2%153.7%58.9% 
Cost of goods sold   [+]57.147.843.737.831.824.415.19.3
Gross profit  61.058.154.249.440.429.925.123.1
            Gross margin  51.6%54.9%55.3%56.7%55.9%55.1%62.5%71.3%
Selling, general and administrative   [+]112.2116.6120.7121.4111.9118.5102.389.1
Research and development  2.32.32.53.84.58.811.311.1
Other operating expenses     3.6    
EBITDA   [+]-20.8-28.6-38.8-52.1-55.6-84.5-82.5-73.6
            EBITDA margin  -17.6%-27.0%-39.6%-59.8%-77.0%-155.7%-205.1%-227.0%
Depreciation and amortization  36.335.833.827.320.513.06.03.5
EBIT   [+]-57.1-64.4-72.6-79.4-76.1-97.5-88.5-77.1
            EBIT margin  -48.4%-60.8%-74.1%-91.0%-105.4%-179.6%-220.0%-237.7%
Non-recurring items   [+]32.832.114.2 9.65.1  
Interest expense  27.027.024.918.612.56.11.40.9
Other income (expense), net   [+]0.10.71.91.71.35.74.44.6
Pre-tax income  -116.8-122.8-109.7-105.9-96.8-103.0-85.5-73.4
Income taxes  0.72.40.80.8-0.2-0.1-0.4-0.7
            Tax rate  -0.6%    0.1% 0.9%
Net income  -117.5-125.2-110.6-106.7-96.7-103.0-85.2-72.7
            Net margin  -99.5%-118.2%-112.9%-122.3%-133.9%-189.8%-211.8%-224.4%
   
Basic EPS   [+]($1.76)($1.89)($1.70)($1.65)($1.50)($1.69)($1.59)($1.60)
Diluted EPS   [+]($1.76)($1.89)($1.70)($1.65)($1.50)($1.69)($1.59)($1.60)
   
Shares outstanding (basic)   [+]66.666.365.164.764.360.953.645.5
Shares outstanding (diluted)   [+]66.666.365.164.764.361.053.745.5
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy